会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 22. 发明授权
    • Process for recovering a dipeptide derivative
    • 回收二肽衍生物的方法
    • US4487717A
    • 1984-12-11
    • US415912
    • 1982-09-08
    • Kiyotaka OyamaShigeaki IrinoNorio Hagi
    • Kiyotaka OyamaShigeaki IrinoNorio Hagi
    • C07K5/072C07K5/075C07C103/52
    • C07K5/0613Y10S530/801
    • A process for recovering a dipeptide derivative comprises admixing an aqueous mixture of a solid dipeptide ester derivative of the formula ##STR1## wherein R.sub.1 is a lower alkyl group, R.sub.2 is a side chain group of an amino acid, n is 1 or 2, X is a benzyloxycarbonyl group which can have a nuclear substituent and Y is a hydrogen ion or an ammonium derivative ion of the formula ##STR2## wherein R.sub.3 is a side chain group of an amino acid and R.sub.4 is a lower alkyl group with an organic solvent capable of forming a binary phase system with water; said solvent being present in an amount effective to obtain the transfer of said peptide in the form of a solid from the aqueous phase to the organic solvent phase, settling the resulting admixture to form(1) an organic solvent phase containing in a solid state a substantial amount of dipeptide derivative of the formula ##STR3## wherein R.sub.1, R.sub.2, n and X are as defined above and Z is a hydrogen ion or an ammonium derivative ion of the formula ##STR4## wherein R.sub.3 and R.sub.4 are as defined above, and (2) an aqueous phase, separating the organic solvent phase from the aqueous phase, and recovering the dipeptide derivative from the organic solvent phase.
    • 回收二肽衍生物的方法包括混合式(I)的固体二肽酯衍生物的水性混合物,其中R1是低级烷基,R2是氨基酸的侧链基团,n是1或 2,X是可以具有核取代基的苄氧基羰基,Y是氢离子或式(II)的铵衍生物离子,其中R3是氨基酸的侧链基团,R4是低级烷基 与能够与水形成二元相体系的有机溶剂组合; 所述溶剂的存在量有效地获得将固体形式的所述肽从水相转移到有机溶剂相,沉淀所得混合物以形成(1)含有固态的有机溶剂相a (III)的大量二肽衍生物,其中R 1,R 2,n和X如上所定义,Z是下式的氢离子或铵衍生物离子,其中R 3和R 4 如上所定义,和(2)水相,将有机溶剂相与水相分离,并从有机溶剂相中回收二肽衍生物。
    • 27. 发明授权
    • Process for recovering protease
    • 回收蛋白酶的方法
    • US4212946A
    • 1980-07-15
    • US907203
    • 1978-05-18
    • Yuji NonakaKiyotaka OyamaHeijiro Satoh
    • Yuji NonakaKiyotaka OyamaHeijiro Satoh
    • C12N9/00C07K5/06C07K5/075C12N9/50C12P21/02C12N9/48C07G7/02
    • C12N9/50C12P21/02Y10S435/816
    • Protease is recovered by reacting a first amino acid whose amino group is protected with a protective group with a second amino acid whose carboxyl group is protected with a protective group, in an aqueous medium in the presence of a protease to result a peptide synthesis to deposit the addition compound of a dipeptide and said second C-terminal protected amino acid; dissolving said addition compound by adding an organic solvent to a precipitate separated from the reaction mixture and isolating the protease from an organic solvent suspension or dissolving said addition compound by adding a water immiscible organic solvent and separating the organic solvent phase by a liquid-liquid separation.The addition compound can be dissolved in an organic solvent after separating the precipitate from the reaction mixture.The addition compound can be also dissolved by adding a water-immiscible organic solvent to the reaction mixture and the organic solvent phase can be separated from the aqueous phase.
    • 通过使氨基被保护基团的第一个氨基酸与其羧基被保护基团保护的第二个氨基酸在水性介质中在蛋白酶存在下反应,从而使肽合成沉积,从而回收蛋白酶 二肽和所述第二C末端保护的氨基酸的加成化合物; 通过向从反应混合物分离的沉淀物中加入有机溶剂来溶解所述加成化合物,并从有机溶剂悬浮液中分离蛋白酶或通过加入与水不混溶的有机溶剂溶解所述加成化合物并通过液 - 液分离分离有机溶剂相 。 在从反应混合物中分离出沉淀物后,加成化合物可以溶解在有机溶剂中。 加成化合物也可以通过向反应混合物中加入与水不混溶的有机溶剂而溶解,并且有机溶剂相可以与水相分离。
    • 29. 发明授权
    • Precursors for prostaglandin analogue and process for preparing the same
    • 前列腺素类似物的前体及其制备方法
    • US4169199A
    • 1979-09-25
    • US862328
    • 1977-12-20
    • Kiyosi KondoDaiei TunemotoYuriko Takahatake
    • Kiyosi KondoDaiei TunemotoYuriko Takahatake
    • C07C405/00C07D309/10
    • C07C405/0033
    • Bicyclolactone compounds represented by the formula (I) ##STR1## wherein R.sup.1 represents an alkyl group having 1 to 4 carbon atoms, R.sup.2 represents a substituted or unsubstituted alkyl group having 1 to 8 carbon atoms and R.sup.3 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms;.gamma.-lactone sulfide or sulfoxide compounds represented by the formula (II) ##STR2## wherein R.sup.2 and R.sup.3 are as defined above, R.sup.4 represents a hydrogen atom or a --COOR.sup.1 group wherein R.sup.1 is as defined above, R.sup.5 represents a hydrogen atom or a --CH.sub.2 --Y--(CH.sub.2).sub.n --COOR.sup.6 group wherein Y represents a --CH.sub.2 CH.sub.2 -- group or a --CH.dbd.CH-- group, R.sup.6 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms and n is an integer of 0 to 6, R.sup.7 represents an alkyl group having 1 to 4 carbon atoms or an aryl group and m is 0 or 1, useful as precursors for prostaglandin analogues; and process for preparing the same.
    • 由式(I)表示的双环内酯化合物其中R 1表示具有1至4个碳原子的烷基,R 2表示取代或未取代的碳原子数1〜8的烷基,R 3表示氢原子或 具有1至4个碳原子的烷基; (II)表示的γ-LACTON硫化物或硫化物化合物其中R 2和R 3如上所定义,R 4表示氢原子或-COOR 1基团,其中R 1如上所定义,R 5表示氢 原子或-CH 2 -Y-(CH 2)n -COOR 6基团,其中Y表示-CH 2 CH 2 - 基或-CH = CH-基,R 6表示氢原子或具有1至4个碳原子的烷基,n为 0〜6的整数,R7表示碳原子数为1〜4的烷基或芳基,m为0或1,可用作前列腺素类似物的前体; 及其制备方法。